142 results
8-K
tdtdhv58
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
PRE 14C
1i96c
16 Dec 22
Preliminary information
4:31pm
8-K
EX-10.2
q6kyo9p37m4w8v24avgt
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
lhy7qu
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
ykha 28k9
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
p2g i0prg
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm